𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Preoperative combined modality therapy for stage III M0 non-small cell lung carcinoma

✍ Scribed by M. Pincus; S. Reddy; M.S. Lee; P. Bonomi; S. Taylor IV; K. Rowland; L.P. Faber; W. Warren; C.F. Kittle; F.R. Hendrickson

Publisher
Elsevier Science
Year
1987
Tongue
English
Weight
122 KB
Volume
13
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Combined modality therapy for locally ad
Combined modality therapy for locally advanced non-small cell lung carcinoma
✍ D. Recine; K. Rowland; S. Reddy; M. S. Lee; P. Bonomi; S. Taylor IV; L. P. Faber πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 691 KB

Multi-modality treatment consisting of cisplatin, VP-16, and 5-fluorouracil chemotherapy given concomitantly with external beam radiation was used to treat 64 patients with locally advanced Stage I11 non-small cell lung carcinoma. This regimen was used in a preoperative fashion for four cycles in pa

A 10-year experience with combined modal
A 10-year experience with combined modality therapy for stage III small cell lung carcinoma
✍ Renee H. Jacobs; Alice Greenburg; Jacob D. Bitran; Philip C. Hoffman; Kathy S. A πŸ“‚ Article πŸ“… 1986 πŸ› John Wiley and Sons 🌐 English βš– 693 KB

During the past 10 years, 240 patients with Stage I11 small cell lung carcinoma (SCLC) were treated with one of five chemotherapy programs plus thoracic irradiation. In addition, prophylactic cranial irradiation was administered concurrently with thoracic irradiation to 194 patients receiving CAML-H

Results of combined-modality therapy for
Results of combined-modality therapy for limited-stage small cell lung carcinoma in the elderly
✍ Steven E. Schild; Philip J. Stella; Burke J. Brooks; Sumithra Mandrekar; James A πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 106 KB πŸ‘ 2 views

## Abstract ## BACKGROUND A Phase III trial was conducted by the North Central Cancer Treatment Group to determine whether chemotherapy (etoposide and cisplatin) plus either twice‐daily radiotherapy (BIDRT) or once‐daily radiotherapy (QDRT) resulted in a better outcome for patients with limited‐st